Stocktoria
GoodRx Holdings, Inc. GDRX
GoodRx Holdings, Inc. (GDRX) earns a Piotroski F-score of 6/9 (mixed financial health), with an Altman Z″ in the distress zone. It does not currently pay a dividend. FY2025 revenue was $796.9M at a 3.8% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Analyst price target
Wall Street analyst consensus — a sentiment gauge, not our scoring.
How it ranks in Services · percentile among 982 companies
Percentile vs other Services companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 6/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · distress zone
| Component | Value |
|---|---|
| Working capital / assets | 0.283 |
| Retained earnings / assets | -1.005 |
| EBIT / assets | 0.062 |
| Equity / liabilities | 0.782 |
Sector peers · similar-size Services companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| GDRX | GoodRx Holdings, Inc. | 6/9 | -0.18 | 31.2 | +0.6% |
| UPWK | UPWORK, INC | 6/9 | 3.27 | 9 | +2.4% |
| RAMP | LiveRamp Holdings, Inc. | 6/9 | 9.25 | 15.7 | +9% |
| NRDS | NERDWALLET, INC. | 7/9 | 6.63 | 12.3 | +21.7% |
| EGHT | 8X8 INC /DE/ | 6/9 | -3.7 | 148.8 | +2.9% |
| CARS | Cars.com Inc. | 6/9 | -1.06 | 30 | +0.6% |
| CARG | CarGurus, Inc. | 7/9 | 7.44 | 19.1 | +13.7% |
About GoodRx Holdings, Inc.
GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscription programs and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. In addition, the company provides healthcare products and solutions for dogs, cats, and other pets. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.
FAQ
Is GDRX financially healthy?
GoodRx Holdings, Inc.'s Piotroski F-score is 6/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.
Does GDRX pay a dividend?
No, GoodRx Holdings, Inc. does not currently pay a dividend.
How profitable is GDRX?
In FY2025, GoodRx Holdings, Inc. had a net margin of 3.8% and a return on equity of 4.9%.
What is GDRX's P/E ratio?
GoodRx Holdings, Inc.'s trailing price-to-earnings (P/E) ratio is about 31.2×, based on its latest annual earnings.
What is the analyst price target for GDRX?
The average Wall-Street price target for GoodRx Holdings, Inc. is $3.18, about 11.4% below the recent price, from 13 analysts (consensus: hold).
Is GDRX a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on GoodRx Holdings, Inc.: a Piotroski F-score of 6/9, an Altman Z″ in the distress zone, a P/E of about 31.2×. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.